Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,855.8
-1.7 (-0.06%)

 

  • STI Straits Times Index
    2,855.8
    -1.7 (-0.06%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,607.6
    -4.5 (-0.28%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,894.7
    75.2 (0.28%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,408.3
    38.6 (1.14%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    26,644.7
    107.4 (0.40%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,783.3
    23.4 (0.41%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,405.7M
  • Value: 1,046.1M
  • Rise: 173
  • Fall: 135
  • Unch: 466

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Alset0.083+0.019
Oceanus^0.025-0.002
Jiutian Chemical0.088+0.001
Sembcorp Marine0.168-0.001
Intl Cement0.071+0.002
QT Vascular0.007-
Broadway Ind0.163+0.006
YZJ Shipbldg SGD0.920-0.010
ThaiBev0.750+0.005
Adventus0.027-

World Indices

World Indices
Name Last Change
Nasdaq 12,094.4 +57.6
HSI 26,894.7 +75.2
HSCEI 10,790.3 +88.8
Jakarta 5,783.3 +23.4
Nikkei 225 26,644.7 +107.4
SSE Comp 3,408.3 +38.6
Shanghai A 3,572.4 +40.5
Shanghai B 244.7 -1.3
KOSPI 2,633.4 +7.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

3SBIO 3SBIO INC
Quotes 15 Minutes Delayed. Updated at 27 Nov 2020 16:09
Last (HKD): 7.450 Change: +0.120 High: 7.500 Remarks: -
Change (%): +1.64 Low: 7.270
Open 7.340 Yesterday's Close 7.330
Buy Price 7.450 Sell Price 7.460
Buy Volume ('000) 1.5 Sell Volume ('000) 11
Cumulative Volume ('000) 6,571.485 Cumulative Value 48,608,419
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 0.43408 Trailing EPS (HKD) e 0.59031 NAV (HKD) b 4.5988
PE a 17.163 Trailing PE f 12.621 Price / NAV b 1.6200
Dividend (HKD) d - Cash In Hand (HKD) g 1.6434 Issued & Paid-up Shares c 2,543,600,000
Dividend Yield (%) d - Price / Cash In Hand g 4.533 Treasury Shares h -
Beta - 75 Daysi 0.600 R-Squared - 75 Days(%)i 8.42 Market Cap (M) 18,949.820
Beta - 500 Daysi 1.215 R-Squared - 500 Days (%)i 23.11 Enterprise Value (M) 19,626.756
Piotroski F Score 8 Exchange Code 1530 Par Value ( USD ) n.a.
52 Weeks Volatility (%) 57.60 6-Month VWAP 9.722 Free Float (%) 53.9
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 08 Oct 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 01 Oct 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference 3SBIO HKEx 18,949.820 17.163 12.621 1.6200 -
Industry Biotechnology HKEx 36,250.625 - - 7.1666 0.152
Local Peer WUXI BIO HKEx 310,653.898 - - - -
Local Peer BEIGENE HKEx 187,206.682 - - 5.6340 -
Local Peer SINO BIOPHARM HKEx 143,158.785 46.642 52.054 4.1462 0.701
Local Peer ZAI LAB-SB HKEx 70,040.774 - - 19.4149 -
Local Peer GENSCRIPT BIO HKEx 21,062.251 - - 2.8807 -
Local Peer ALPHAMAB-B HKEx 13,855.796 - - 4.8934 -
Local Peer VIVA BIOTECH HKEx 13,444.664 44.595 - 6.4632 0.232
Local Peer JW THERAP-B HKEx 9,253.930 - - -9.1311 -
Local Peer JHBP-B HKEx 8,907.284 - - 58.2905 -
Local Peer HAOHAI BIOTEC HKEx 7,821.958 18.605 32.707 1.2850 1.742
Local Peer FRONTAGE HKEx 7,727.490 53.506 73.129 3.6637 -
Local Peer ASCENTAGE-B HKEx 5,607.500 - - 8.3601 -
Other Local Peers KINTOR PHARMA-B (HKEx), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), LEE'S PHARM (HKEx), ESSEX BIO-TECH (HKEx), UNI-BIO GROUP (HKEx), CT ENTERPRISE (HKEx), REGENT PACIFIC (HKEx), BIOSINO BIO-TEC (HKEx), HAO WEN HLDGS (HKEx)
Global Peer AMGEN INC NASDAQ 130,877.413 16.689 17.802 11.9425 2.621
Global Peer CSL ASX 137,857.122 43.955 43.955 14.5410 0.969
Global Peer GILEAD SCIENCES INC NASDAQ 75,249.406 13.971 59.345 4.3135 4.240
Global Peer VERTEX PHARMACEUTICAL NASDAQ 58,953.215 50.096 21.910 7.2482 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 54,852.204 25.925 17.380 5.4172 -
Global Peer MODERNA INC NASDAQ 50,267.041 - - 18.2140 -
Global Peer ILLUMINA INC NASDAQ 46,286.380 46.194 72.549 9.8482 -
Global Peer BIOGEN INC NASDAQ 37,513.354 6.371 7.381 3.4869 -
Global Peer SEAGEN INC NASDAQ 30,493.351 - 64.549 13.5044 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 27,099.576 11.271 28.329 2.4469 -
Other Global Peers BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), 10X GENOMICS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), NOVAVAX INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), FATE THERAPEUTICS (NASDAQ), IMMUNOVANT INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), ALLOGENE THERAPEUTICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), PTC THERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), INSMED INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), FIBROGEN INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), ALKERMES PLC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), XENCOR INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ALLOVIR INC (NASDAQ), VIELA BIO INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), NANOSTRING TECHNOLOGIES INC (NASDAQ), UNIQURE N.V. (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), VAXCYTE INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MESOBLAST LTD (ASX), MERSANA THERAPEUTICS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), NGM BIOPHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), CORTEXYME INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), PRECIGEN INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), MACROGENICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), CYTOKINETICS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), NKARTA INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), INHIBRX INC (NASDAQ), PERSONALIS INC (NASDAQ), COMPUGEN (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ALECTOR INC (NASDAQ), NANTKWEST INC (NASDAQ), IMMUNOGEN INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ARVINAS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ATHIRA PHARMA INC (NASDAQ), VAXART INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), SQZ BIOTECHNOLOGIES CO (NYSE), RADIUS HEALTH INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), OMEROS CORP (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), AKOUOS INC (NASDAQ), KADMON HLDGS INC (NASDAQ), AGENUS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), DPHARMA (Bursa), VBI VACCINES INC CDA (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), TELIX PHARMACEUTIC (ASX), IMMATICS N V (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), IVERIC BIO INC (NASDAQ), AVROBIO INC (NASDAQ), GERON CORP (NASDAQ), ATRECA INC (NASDAQ), ARDELYX INC (NASDAQ), ONCORUS INC (NASDAQ), OPTHEA LIMITED (ASX), XBIOTECH INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), HUMANIGEN INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), PROTHENA CORP PLC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), AFFIMED N V (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ),